---
figid: PMC3602699__zh20061368720009
figtitle: Summary of signaling pathway by which PP-fold peptides increase cell proliferation
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3602699
filename: zh20061368720009.jpg
figlink: /pmc/articles/PMC3602699/figure/F9/
number: F9
caption: Summary of signaling pathway by which PP-fold peptides increase cell proliferation.
  Components in green circles indicate sites of interventions (noted in red next to
  the green circles) conducted in this study. DPPIV, dipeptidyl peptidase IV; NPY1–36,
  neuropeptide Y1–36; PYY1–36, peptide YY1–36; NPY3–36, neuropeptide Y3–36; PYY3–36,
  peptide YY3–36; Gi, inhibitory G-protein; βγ, βγ subunits of G protein; PLC, phospholipase
  C; PKC, protein kinase C; DAG, diacyglycerol; IP3, inositol trisphosphate; Ca2+,
  calcium; RACK1, receptor for activated C kinase 1; ERKs, extracellular-signal-regulated
  kinases; PI3Ks, phosphatidylinositol 3-kinases; DPI, diphenyleneiodonium; SFKs,
  src family kinases; mTOR, mammalian target of rapamycin; ROCK, Rho-associated protein
  kinase; p38 MAPKs, p38 mitogen-activated protein kinases; NADPH oxidase, nicotinamide
  adenine dinucleotide phosphate oxidases.
papertitle: Role of RACK1 in the differential proliferative effects of neuropeptide
  Y1–36 and peptide YY1–36 in SHR vs. WKY preglomerular vascular smooth muscle cells.
reftext: Dongmei Cheng, et al. Am J Physiol Renal Physiol. 2013 Mar 15;304(6):F770-F780.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8904151
figid_alias: PMC3602699__F9
figtype: Figure
redirect_from: /figures/PMC3602699__F9
ndex: 8b05a6b7-df12-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3602699__zh20061368720009.html
  '@type': Dataset
  description: Summary of signaling pathway by which PP-fold peptides increase cell
    proliferation. Components in green circles indicate sites of interventions (noted
    in red next to the green circles) conducted in this study. DPPIV, dipeptidyl peptidase
    IV; NPY1–36, neuropeptide Y1–36; PYY1–36, peptide YY1–36; NPY3–36, neuropeptide
    Y3–36; PYY3–36, peptide YY3–36; Gi, inhibitory G-protein; βγ, βγ subunits of G
    protein; PLC, phospholipase C; PKC, protein kinase C; DAG, diacyglycerol; IP3,
    inositol trisphosphate; Ca2+, calcium; RACK1, receptor for activated C kinase
    1; ERKs, extracellular-signal-regulated kinases; PI3Ks, phosphatidylinositol 3-kinases;
    DPI, diphenyleneiodonium; SFKs, src family kinases; mTOR, mammalian target of
    rapamycin; ROCK, Rho-associated protein kinase; p38 MAPKs, p38 mitogen-activated
    protein kinases; NADPH oxidase, nicotinamide adenine dinucleotide phosphate oxidases.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NPY
  - PYY
  - DPP4
  - FAP
  - RACK1
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MTOR
  - DECR1
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - ROCK1
  - ROCK2
  - PPA1
  - NPY4R
  - NPY4R2
  - U73122
  - PD98059 LY294002
  - SB203580
  - Rapamycin
---
